CLRD Stock Overview
Clearday, Inc. provides tech-enabled non-acute care and wellness solutions.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Clearday, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.62 |
| 52 Week High | US$1.45 |
| 52 Week Low | US$0.25 |
| Beta | 1.43 |
| 1 Month Change | 100.00% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -82.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLRD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 19.2% | 0.6% | 1.0% |
| 1Y | 0% | 2.2% | 21.9% |
Return vs Industry: CLRD underperformed the US Healthcare industry which returned 3.4% over the past year.
Return vs Market: CLRD underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| CLRD volatility | |
|---|---|
| CLRD Average Weekly Movement | 37.5% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CLRD's share price has been volatile over the past 3 months.
Volatility Over Time: CLRD's weekly volatility has increased from 30% to 38% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 225 | Jim Walesa | myclearday.com |
Clearday, Inc. provides tech-enabled non-acute care and wellness solutions. The company operates residential memory care communities in three U.S. states. It offers Clearday Clubs, a membership-based centers that provides adult day care and long-term residential care alternatives; and Clearday Labs, which provides development of digital and robotic services.
Clearday, Inc. Fundamentals Summary
| CLRD fundamental statistics | |
|---|---|
| Market cap | US$16.78m |
| Earnings (TTM) | -US$21.54m |
| Revenue (TTM) | US$7.06m |
2.4x
P/S Ratio-0.8x
P/E RatioIs CLRD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLRD income statement (TTM) | |
|---|---|
| Revenue | US$7.06m |
| Cost of Revenue | US$5.28m |
| Gross Profit | US$1.77m |
| Other Expenses | US$23.32m |
| Earnings | -US$21.54m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.80 |
| Gross Margin | 25.14% |
| Net Profit Margin | -305.24% |
| Debt/Equity Ratio | -71.9% |
How did CLRD perform over the long term?
See historical performance and comparison